期刊文献+

畲药食凉茶组方结合西药治疗痰湿壅盛型原发性高血压30例 被引量:14

"Shiliangcha Prescription" of "She medicine" combined with western medicine in treating essential hypertension of damp-phlegm pattern: A report of 30 cases
下载PDF
导出
摘要 目的观察畲药食凉茶组方结合西药治疗痰湿壅盛型原发性高血压的临床疗效。方法将60例患者随机分为治疗组和对照组(各30例),两组均采用西医常规疗法,治疗组同时加用畲药食凉茶组方。两组疗程均为2个月,观察中医证候疗效及血压、NO、ET水平变化情况。结果治疗组、对照组中医证候总有效率分别为93.3%、70.0%;组间中医证候疗效比较,差异有统计学意义(P<0.05)。与本组治疗前比较,两组中医证候积分均明显下降(P<0.05);组间治疗后比较,差异有统计学意义(P<0.05)。两组收缩压、舒张压及NO、ET治疗前后组内比较,差异有统计学意义(P<0.05);组间治疗后比较,收缩压、舒张压及NO、ET差异均有统计学意义(P<0.05)。结论畲药食凉茶组方结合西药可有效用于痰湿壅盛型原发性高血压的治疗。 Objective To observe the clinical efficacy of "Shiliangcha Prescription" combined with western medicine in treating essential hypertension of dampphlegm pattern. Methods Sixty subjects were randomized into two groups:treatment group in which 30 cases were treated with "Shiliangcha Prescription" combined with western medicine and control group in which 30 cases were treated with western medicine, with a course of 2 months. The clinical efficacy, levels of blood pressure, NO and ET were observed. Results The total effective rates were 93.3% and 70.0% in treatment group and control group respectively. The difference of therapeutic effects was significant between the two groups (P 〈0.05 ). The symptom scores were decreased significantly in both groups after treatment ( P 〈0.05 ) , and the difference was significant between the two groups after treatment ( P 〈0.05 ). There were significant differences in systolic pressure, diastolic pressure, NO and ET in both groups between before and after treatment ( P〈0.05 ) ; there were significant differences in systolic pressure, diastolic pressure, NO and ET between the two groups after treatment ( P 〈0.05 ). Conclusion "Shiliangcha Prescription" of "She medicine" combined with western medicine is quite effective for the essential hypertension of damp-phlegm pattern.
出处 《上海中医药杂志》 2012年第3期49-50,64,共3页 Shanghai Journal of Traditional Chinese Medicine
基金 浙江省丽水市科技项目(2010JYZB21)
关键词 原发性高血压 痰湿壅盛 中西医结合疗法 食凉茶 essential hypertension damp-phlegm pattern integrative Chinese and western medicine "Shiliangcha"
  • 相关文献

参考文献4

二级参考文献30

  • 1虞金宝,吕武清,李才堂,李晶,宋友昕.HPLC测定田基黄注射液中槲皮素含量[J].中成药,2005,27(1):100-101. 被引量:8
  • 2边清泉,杨振萍.RP-HPLC测定槐角丸中槲皮素和染料木素的含量[J].中成药,2005,27(7):766-769. 被引量:9
  • 3徐素珍 吴玉玲 王英.控制高血压干预活动与社区卫生服务结合的尝试.中国健康教育,1998,12:36-36.
  • 4[17]Yoshizumi M,Tsuchiya K,Suzaki Y,et al.Quercetin glucuronide prevents VSMC hypertrophy by angiotensin Ⅱ via the inhibition of JNK and AP-1 signaling pathway[J].Biochem Biophys Res Commun,2002,293(5):1458-1465.
  • 5[18]Moon SK,Cho GO,Jung SY,et al.Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells:role of ERK1/2,cell-cycle regulation,and matrix metalloproteinase-9[J].Biochem Biophys Res Commun,2003,301 (4):1069-1078.
  • 6[19]Plotnikov MB,Aliev OI,Maslov MJ,et al.Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid[J].Phytother Res,2003,17 (1):86-88.
  • 7[20]Fan PS,Gu ZL,Liang ZQ.Effect of quercetin on adhesion of platelets to microvascular endothelial cells in vitro[J].Acta Pharmacol Sin,2001,22(9):857-860.
  • 8[21]Hubbard GP,Wolffram S,Lovegrove JA,et al.Ingestion of quercetin inhibits platelet aggregation and essential com ponents of the collagen-stimulated platelet activation pathway in humans[J].J Thromb Haemost,2004,2(12):2138-2145.
  • 9[1]Duarte J,Jimenez R,O'Valle F,et al.Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats[J].J Hypertens,2002,20(9):1843-1854.
  • 10[2]Kuhlmann CR,Schaefer CA,Kosok C,et al.Quercetin-induced induction of the NO/cGMP pathway depends on Ca2+-activated K+ channel-induced hyperpolarization-mediated Ca2+ -entry into cultured human endothelial cells[J].Planta Med,2005,71(6):520-524.

共引文献54

同被引文献232

引证文献14

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部